🛒 Shopee 蝦皮購物 — 熱門好物,點此搶購! ➔

Boehringer Ingelheim looks to Korean biotech for next drug breakthroughs

Korea is moving beyond its traditional role as a market for medicines to become a source of pharmaceutical innovation, with local biotech partnerships and clinical research expected to play a larger role in global drug development, Boehringer Ingelheim CEO Shashank Deshpande says. “We do not anymore

Boehringer Ingelheim looks to Korean biotech for next drug breakthroughs

Korea is moving beyond its traditional role as a market for medicines to become a source of pharmaceutical innovation, with local biotech partnerships and clinical research expected to play a larger role in global drug development, Boehringer Ingelheim CEO Shashank Deshpande says. “We do not anymore

原文連結:KoreaHerald

💬 留言板 — 歡迎分享你的想法!

載入留言中...